Macrì, Simone http://orcid.org/0000-0003-2946-4784
Spinello, Chiara
Widomska, Joanna
Magliozzi, Roberta
Poelmans, Geert
Invernizzi, Roberto William
Creti, Roberta
Roessner, Veit
Bartolini, Erika
Margarit, Immaculada
Glennon, Jeffrey
Laviola, Giovanni
Funding for this research was provided by:
European Commission (278367, 278367, 316978, 603016, 278948, 278367)
Article History
Received: 8 March 2018
Accepted: 12 June 2018
First Online: 5 July 2018
Competing Interests
: The authors declare that they have no non-financial interest to disclose. S.M., C.S., J.W., R.M., G.P., R.W.I., R.C., V.R., J.G. and G.L. have no financial interest to disclose. E.B. and I.M. were employees of Novartis Vaccines at the time of the study; in March 2015 the Novartis non-influenza Vaccines business was acquired by the GSK group of companies. E.B. and I.M. are now employees of the GSK group of companies. I.M. and E.B. are listed as inventors on patents owned by the GSK group of companies. I.M. reports ownership of restricted GSK shares.